Over 30 financial institutions from East China's Shanghai visited China Medical City, a bio-medical industrial park in Taizhou city, in East China's Jiangsu province, to explore opportunities for integration between the pharmaceutical industry and the financial sector on Sept 21.
An industry-finance matchmaking meeting is held in Taizhou city on Sept 21. [Photo by Fang Yuting]
The event focused on promoting the development of the real economy through collaboration between these two sectors.
During her address, Taizhou Mayor Wan Wenhua spoke about the urgent need for capital in the comprehensive healthcare sector, and highlighted Taizhou's commitment to integrating the industrial, innovation, and capital chains.
To support this integration, Taizhou has introduced various incentives and policies, including support for equity investment, enterprise listings, scientific and technological innovation, and talent acquisition.
Huang Yunhai, director of the Jiangsu Provincial Government Office in Shanghai, praised Taizhou's business environment, policy advantages, and innovation-driven growth.
He urged Shanghai's financial institutions and investors to increase their investments in Taizhou, as well as support the city's sci-tech innovation and the development of the health industry.
During the event, experts from Qyuns Therapeutics and the Shanghai Stock Exchange gave keynote speeches on direct financing in the capital market and its significance for the pharmaceutical industry.
Five pharmaceutical enterprises from Taizhou, including Universalvax Biotechnologies (Taizhou) Co Ltd and Weihe Biotechnology INC., also presented their projects.